Literature DB >> 7008760

Filarial chyluria associated glomerulonephritis and therapeutic considerations in the chyluric patient.

D A Waugh, J H Alexander, L S Ibels.   

Abstract

Two patients with chyluria who were successfully treated by surgical disconnection of the lymphatics from the renal pelvis are reported. One patient also had an associated glomerulonephritis, possibly secondary to filariasis. Although glomerulonephritis associated with filariasis has been reported previously the details of renal biopsies in man have included only light microscopic findings. In this patient immunofluorescent and electron microscopic studies showed mesangial deposits of immunoglobulins and complement which suggests that glomerulonephritis in patients with filariasis may be an immune complex type.

Entities:  

Mesh:

Year:  1980        PMID: 7008760     DOI: 10.1111/j.1445-5994.1980.tb04977.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  5 in total

Review 1.  Pathogenesis of lymphatic filariasis in man.

Authors:  D H Connor; J R Palmieri; D W Gibson
Journal:  Z Parasitenkd       Date:  1986

2.  Antigen-specific immune complexes in urine of patients with lymphatic filariasis.

Authors:  Vandana Dixit; A V Subhadra; P S Bisen; B C Harinath; G B K S Prasad
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

3.  Immune complex glomerulonephritis and chronic anaerobic urinary infection--complications of filariasis.

Authors:  A D Ormerod; J Petersen; J K Hussey; J Weir; N Edward
Journal:  Postgrad Med J       Date:  1983-11       Impact factor: 2.401

Review 4.  Infections and the kidney: a tale from the tropics.

Authors:  Nivedita Kamath; Arpana Iyengar
Journal:  Pediatr Nephrol       Date:  2017-09-06       Impact factor: 3.651

Review 5.  The role of helminths in the development of non-communicable diseases.

Authors:  Yifan Wu; Megan Duffey; Saira Elizabeth Alex; Charlie Suarez-Reyes; Eva H Clark; Jill E Weatherhead
Journal:  Front Immunol       Date:  2022-08-31       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.